RESEARCH-USE BIOSIMILAR ANTIBODY
Alacizumab
Antibody fragment · IgG1 kappa
Alacizumab is a CHO-expressed humanized antibody that targets VEGFR2/KDR/CD309. Alacizumab contains huIgG1 heavy chain and huκ light chain, with a predicted molecular weight (MW) of 144.08 kDa. The isotype control for Alacizumab can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).
TARGETKDR
YAntibody fragment
CATALOGSC-BS-782
CATALOG NUMBERSC-BS-782
MOLECULAR WEIGHTLot-specific
PRODUCT FORMATAntibody fragment
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Alacizumab is a CHO-expressed humanized antibody that targets VEGFR2/KDR/CD309. Alacizumab contains huIgG1 heavy chain and huκ light chain, with a predicted molecular weight (MW) of 144.08 kDa. The isotype control for Alacizumab can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).
Alacizumab is a recombinant research-use antibody directed against KDR.